LOUISVILLE, Ky., Aug. 23, 2024 /PRNewswire/ — RAAPID, a leader in advanced risk adjustment technologies, is proud to announce its sponsorship and participation in RISE West 2024, scheduled for September 11-13 in Colorado Springs. This premier event gathers the healthcare industry’s top professionals and focuses on the latest advancements in risk adjustment, value-based care, and clinical documentation improvement (CDI).
At RISE West 2024, RAAPID will showcase its state-of-the-art Prospective Risk Adjustment AI platform, an end-to-end solution meticulously designed to enhance every phase of clinical encounters. With two successful PoCs (Proof of concept) with large & live customer provider settings, RAAPID believes this solution is the need of the hour for this industry. RAAPID was delivered and identified per patient revenue opportunity of $10K+, demonstrating significant ROI (return on investment). From pre-visit to post-visit, RAAPID’s platform leverages Neuro-Symbolic AI to elevate the capture of recaptured and suspecting chronic conditions accurately by analyzing structured and unstructured clinical data. It ensures that healthcare providers capture the most comprehensive and precise risk profiles, leading to improved patient outcomes, reduced provider’s (including care team) abrasion, and optimized revenue integrity.
Key Features of RAAPID’s Prospective Risk Adjustment Solution:
RAAPID’s solution is uniquely positioned to meet the demands of today’s healthcare environment, where the shift to value-based care necessitates precise, efficient, and compliant risk adjustment processes. By integrating advanced AI and NLP technologies, RAAPID’s platform increases coding accuracy and reduces clinician workload, allowing providers to focus on what matters most—patient care.
“We are excited to introduce our latest innovations at RISE West 2024,” said Michael Clark, President & Chief Growth Officer at RAAPID. “Our goal is to equip payers and providers with the tools they need to enhance operational efficiency, drive better patient outcomes, ROI, and achieve more accurate and compliant risk adjustment.”
About RAAPID
RAAPID is a healthcare technology innovator serving payers, providers, and supporting organizations. Utilizing artificial intelligence, machine learning, clinically trained natural language processing, and knowledge graphs, RAAPID powers workflow applications that facilitate the transition to value-based care. RAAPID’s cloud-based Risk Adjustment platform, available as SaaS and API, processes structured and unstructured patient data to accurately identify chronic conditions, determine HCC codes, calculate risk scores, and analyze population health trends. Serving providers & payers involved in value-based care settings, Medicare Advantage, ACA, and Medicare ACO programs, RAAPID delivers solutions that drive revenue, capture accurate patient risk, reduce physician burnout, administrative costs, and ensure compliance.
Media Contact:
Mayur Vyas
(502) 699-3044
382150@email4pr.com
SOURCE RAAPID
RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…
NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen…
SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a…
FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”)…
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero…
NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global artificial intelligence-as-a-service (AIaaS) market size is…